1. Home
  2. IBRX vs HRI Comparison

IBRX vs HRI Comparison

Compare IBRX & HRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ImmunityBio Inc.

IBRX

ImmunityBio Inc.

HOLD

Current Price

$8.58

Market Cap

6.1B

Sector

Health Care

ML Signal

HOLD

Logo Herc Holdings Inc.

HRI

Herc Holdings Inc.

HOLD

Current Price

$147.27

Market Cap

5.2B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
IBRX
HRI
Founded
2014
1965
Country
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Misc Corporate Leasing Services
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
6.1B
5.2B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
IBRX
HRI
Price
$8.58
$147.27
Analyst Decision
Strong Buy
Buy
Analyst Count
5
6
Target Price
$11.80
$185.33
AVG Volume (30 Days)
32.9M
588.7K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
1.89%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$680.06
$16.64
Revenue Next Year
$90.34
$5.68
P/E Ratio
N/A
$4,944.33
Revenue Growth
N/A
N/A
52 Week Low
$1.83
$96.19
52 Week High
$8.28
$190.04

Technical Indicators

Market Signals
Indicator
IBRX
HRI
Relative Strength Index (RSI) 72.34 39.19
Support Level $5.93 $176.33
Resistance Level $7.30 $188.35
Average True Range (ATR) 0.81 8.80
MACD -0.00 -1.90
Stochastic Oscillator 96.61 13.36

Price Performance

Historical Comparison
IBRX
HRI

About IBRX ImmunityBio Inc.

ImmunityBio Inc is an integrated clinical-stage biotechnology company discovering, developing, and commercializing next-generation immuno- and cellular therapies that bolster the natural immune system to drive and sustain an immune response. Its platforms for the development of biologic product candidates include (i) antibody-cytokine fusion proteins, (ii) DNA, RNA, and recombinant protein vaccines, and (iii) cell therapies. Its focus includes bladder, lung, and colorectal cancers and GBM and its product candidate Anktiva is an IL-15 superagonist antibody-cytokine fusion protein. It has two geographical segments: the United States and Europe. Key revenue is generated from the United States.

About HRI Herc Holdings Inc.

Herc Holdings is an equipment rental company that was spun out of Hertz Global in 2016. It is currently the third-largest player in North America, after United Rentals and Sunbelt Rentals, with an approximate 6% market share pro forma for its 2025 acquisition of H&E Equipment Services. It serves a similar mix of companies to its peers (industrial, commercial, and residential construction) from its 450 locations targeting the top 100 metropolitan markets in the US. Herc's rental fleet of approximately $7 billion is also similar in composition to its peer group in terms of equipment offered. The company is also pursuing diversification by bundling and increasing specialty solutions for its customer base. Herc's portfolio skews toward local customers versus national accounts (60%/40%).

Share on Social Networks: